Neural tube defects in embryos of diabetic mice: Role of the Pax-3 gene and apoptosis

Diabetes

Volumn 46, Issue 7, 1997, Pages 1189-1197

  Phelan, Shelley A ^a,b   Ito, Moriko ^a,b   Loeken, Mary R ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; EMBRYOPATHY; ETIOLOGY; FEMALE; GENE EXPRESSION; GENE MUTATION; IN SITU HYBRIDIZATION; MESENCEPHALON; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHOMBENCEPHALON;

EID: 0030994305     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.7.1189     Document Type: Article

References (73)

1. Mills JL, Baker L, Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes betes 28:292-293, 1979
2. Hollingsworth DR (Ed.): Pregnancy, Diabetes, and Birth: A Management Guide. Baltimore, Williams and Wilkins, 1992
3. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL: Elevated maternal hemoglobin Alc in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304:1331-1334, 1981
4. Kitzmiller JL, Cloherty JP, Younger MD, Tabatibaii A, Rothchild SB, Sosenko I, Epstein MF, Singh S, Neff RK: Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 131:560-580, 1978
5. Miodovnik M, Mimouni F, Dignan PSJ, Berk MA, Ballard JL, Siddiqi TA, Khoury J, Tsang RC: Major malformations in infants of IDDM women: vasculopathy and early first-trimester poor glycemic control. Diabetes Care 11:713-718, 1988
6. Lucas MJ, Leveno KJ, Williams L, Raskin P, Whalley PJ: Early pregnancy glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 161:426-431, 1989
7. Damm P, Molsted-Pedersen L: Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 161:1163-1167, 1989
8. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, Van Auen M, Holzman I, Ober C, Peterson CM, Withiam MJ, Duckles A, Mueller-Heubach E, Polk BF: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318:671-676, 1988
9. Becerra JE, Khoury MJ, Cordero JF, Erickson JD: Diabetes mellitus during pregnancy and the risks for the specific birth defects: a population-based casecontrol study. Pediatrics 85:1-9, 1990
10. Eriksson UJ, Hakan Borg LA, Forsberg H, Styrud J: Diabetic embryopathy: studies with animal and in vitro models. Diabetes 40 (Suppl. 2):94-98, 1991
11. Eriksson UJ: Diabetes in pregnancy: effects on post-implantation embryos. Israel J Med Sei 27:478-486, 1991
12. Eriksson UJ, Borg LAH: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419, 1993
13. Shum L, Sadler TW: Biochemical basis for D,L,-beta-hydroxybutyrate-induced teratogenesis. Teratology 42:553-563, 1990
14. Engstrom E, Haglund A, Eriksson UJ: Effects of maternal diabetes or in vitro hyperglycemia on uptake of palmitic and arachidonic acid by rat embryos. PediatrRes 30:150-153, 1991
15. Strieleman PJ, Metzger BE: Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus - a role in dysmorphogenesis. Teratology 48:267-278, 1993
16. Cagliero E, Forsberg H, Sala R, Lorenzi M, Eriksson UJ: Maternal diabetes induces increased expression of extracellular matrix components in rat embryos. Diabetes 42:975-980, 1993
17. Copp AJ, Brook FA, Estibeiro P, Shum ASW, Cockroft DL: The embryonic development of mammalian neural tube defects. Prog Neurobiol 35:363-403, 1990
18. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Gruss P: Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 10:1135-1147, 1991
19. Treisman J, Harris E, Desplan D: The paired box encodes a second DNA-binding domain in the Paired homeo domain protein. Genes Dev 5:594-604, 1991
20. Chalepakis G, Tremblay P, Gruss P: Pax genes, mutants and molecular function. J Cell Sci Suppl 16:61-67, 1992
21. Epstein DJ, Vekemans M, Gros P: Splotch (Sp-2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67:767-774, 1991
22. Epstein DJ, Vogan KJ, Trasler DG, Grow P: A mutation within intron 3 of the Pax-3 gene produces aberrantly spliced mRNA transcripts in the splotch (Sp) mouse mutant. Proc Natl Acad Sci USA 90:532-536, 1993
23. Goulding M, Sterrer S, Fleming J, Balling R, Nadeau J, Moore KJ, Brown SDM, Steel KP, Gruss P: Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17:355-363, 1993
24. Chalepakis G, Goulding M, Read A, Strachan T, Gruss P: Molecular basis of splotch and Waardenburg Pax-3 mutations. Proc Natl Acad Sci USA 91:3685-3689, 1994
25. Hogan B, Costantini F, Lacy E (Eds.): Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1986
26. Kaufman MH: Tiie Atlas of Mouse Development. San Diego, CA, Academic Press, 1992
27. Chomczynski P, Sacchi N: Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
28. Kornbligtt AR, Vibe-Pedersen K, Baralle FE: Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Natl Acod Sci USA 80:3218-3222, 1983
29. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977
30. Sasaki H, Hogan BLM: Differential expression of multiple fork head related genes during gastrulation and axial pattern formation in the mouse embryo. Development 118:47-59, 1993
31. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
32. Calabresi P, Parks RE Jr Antiproliferative agents and drugs used for immiunosuppression. In The Pharmacological Basis of Therapeutics. Gilman AG, Goodman LS, Gilman A, Eds. New York, Macmillan, 1980, p. 1256-1313
33. Jaffe RB: Integrative maternal-fetal endocrine control systems. In Reproductive Endocrinology: Physiology, Pathophysiology & Clinical Management. Yen SSC, Jaffe RB, Eds. Philadelphia, PA, W.B. Saunders, 1986, p. 770-788
34. Flier JS, Moses AC: Diabetes in acromegaly and other endocrine disorders. In Endocrinology. DeGroot LJ, Ed. Philadelphia, W.B. Saunders, 1989, p. 1389-1399
35. Freinkel N: Of pregnancy and progeny. Diabetes 29:1023-1035, 1980
36. Karasik A, Hattori M: Use of animal models in the study of diabetes. In Joslin's Diabetes Mellitus. Kahn CR, Weir GC, Eds. Philadelphia, Lea and Febiger, 1994, p. 317-357
37. Vogan KJ, Epstein DJ, Trasler DG, Gros P: The Splotch-Delayed (Sp-d) mouse mutant carries a point mutation within the paired box of the Pax-3 gene. Genomics 17:364-369, 1993
38. Auerbach R: Analysis of the developmental effects of a lethal mutation in the house mouse. J Exp Zool 127:305-329, 1954
39. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL: Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci USA 91:6231-6235, 1994
40. Homma S, Yaginuma H, Oppenheim RW: Programmed cell death during the earliest stages of spinal cord development in the chick embryo: a possible means of early phenotypic selection. J Comp Neurol 345:377-395, 1994
41. Mori C, Nakamura N, Okamoto Y, Osawa M, Shiota K: Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labelling of DNA fragmentation. Anal Embryol 190:21-28, 1994
42. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Socldner JS: First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39:225-231, 1989
43. Miodovnik M, Mimouni F, Siddiqi TA, Khoury J, Berk MA: Spontaneous abortions in repeat diabetic pregnancies: a relationship with glycemic control. Obstet Gynecol 75:75-77, 1990
44. Kioussi C, Gross MK, Gruss P: Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15:553-562, 1995
45. Chalepakis G, Jones FS, Edelman GM, Gruss P: Pax-3 contains domains for transcription activation and transcription inhibition. Proc Natl Acad Sci USA 91:12745-12749, 1994
46. Maulbecker CC, Gruss P: The oncogenic potential of Pax genes. EMBO J 12:2361-2367, 1993
47. Barr EG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS: Rearrangement of the PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma. Nat Genet 3:113-117, 1993
48. Galili N, Davis R, Fredericks WJ, Mukhopadhyay S, Rauscher FJ III, Emanuel BS, Rovera G, Barr FG: Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdonryosarcoma. Nat Genet 5:230-235, 1993
49. King KL, Cidlowski JA: Cell cycle and apoptosis; common pathways to life and death. J Cell Biochem 58:175-180, 1995
50. Goulding M, Lumsden A, Paquette AJ: Regulation of Pax-3 expression in the dermomyotome and its role in muscle development. Development 120:957-971, 1994
51. Mills JL: Malformations in infants of diabetic mothers. Teratology 25:385-394, 1982
52. Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70, 1971
53. Suzuki N, Svensson K, Eriksson UJ: High glucose concentration inhibits migration of rat cranial neural crest cells in vitro. Diabetologia 39:401-411, 1996
54. Eriksson UJ, Dahlstrom E, Larsson KS, Hellerstrom C: Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31:1-6, 1982
55. Zhang S, Kim KH: Glucose activation of acetyl-CoA carboxylase in association with insulin secretion in a pancreatic beta-cell line. J Endocrin 147:33-41, 1995
56. Vaulont S, Kahn A: Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J 8:28-35, 1994
57. Redmon JB, Towle HC, Robertson RP: Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. Diabetes 43:546-551, 1994
58. Poitout V, Olson LK, Robertson RP: Chronic exposure of betaTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Invest 97:1041-1046, 1996
59. Goodison S, Myazaki J, Ashcroft SJ: Response to glucose of transcription factor binding to the rat insulin-1 gene promoter. Biochem Biophys Res Commun 203:702-710, 1994
60. Asfari M, De W, Noel M, Holthuizen PE, Czernichow P: Insulin-like growth factor-II gene expression in a rat insulin-producing beta-cell line (INS-1) is regulated by glucose. Diabetologia 38:927-935, 1995
61. Odagiri H, Wang J, German MS: Function of the human insulin promoter in primary cultured islet cells. J Biol Chem 271:1909-1915, 1996
62. German MS, Wang J: The insulin gene contains multiple transcriptional elements that respond to glucose. Mol Cell Biol 14:4067-4075, 1994
63. Lefrancois-Marinez AM, Martinez A, Antoine B, Raymondjean M, Kahn A: Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem 270:2640-2643, 1995
64. Read ML, Clark AR, Docherty K: The helix-loop-helix transcription factor USF (upstream stimulating factor) binds to a regulatory sequence of the human insulin gene enhancer. Biochem J 295:233-237, 1993
65. Luo X, Sawadogo M: Antiproliferative properties of the USF family of helixloop-helix transcription factors. Proc Natl Acad Sci USA 93:1308-1313, 1996
66. Nishio Y, Waren CE, Buczek-Thomas JA, Rulfe J, Koya D, Aiello LP, Feener EP, Miller TB Jr, Dennis JW, King GL: Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 96:1759-1767, 1995
67. Shin SJ, Lee YJ, Lin SR, Tan MS, Lai YH, Tsai JH: Decrease of renal endothelin 1 content and gene expression in diabetic rats with moderate hyperglycemia. Nephron 70:486-493, 1995
68. Sugimoto H, Shikata K, Makino H, Ota K, Ota Z: Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli. Nephron 72:648-653, 1996
69. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE: Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Ann Rev Med 45:179-188, 1994
70. Giugliano D, Ceriello A: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
71. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:325-331, 1991
72. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, Groner Y: Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc Superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041, 1995
73. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971, 1992